SOUTH SAN FRANCISCO, April 24, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced the appointment of Anne E. Hagey, M.D. as Vice President and Chief Medical Officer. Dr. Hagey will be responsible for all aspects of pre-clinical and clinical development for Hana’s portfolio of cancer therapeutic and supportive care candidates, reporting to Steven R. Deitcher, M.D., Hana’s President and Chief Executive Officer.
